rodrom82
New member
The thing that keeps nagging me is that BPC-157 and TB-500 basically get used together half the time anyway, people stack them for injury recovery, so there's almost an argument for funding a trial that looks at them together instead of picking one. But then you lose the clean "here's exactly what we tested" story if you don't separate them.
BPC-157 has the better paper trail though. It's that stomach-derived fragment, and the animal work on tendons and gut healing is actually decent, not amazing, but decent enough that you could put together a real proposal a lab wouldn't laugh at. TB-500 is more thymosin-related, wound healing and cell migration, and honestly a lot of what people say about it online is just vibes carried over from BPC-157's reputation.
BPC-157 could be probably the honest move. and if such a campaign actually works and funds a real trial, TB-500 could be next because the same audience is already there and already primed for it.
I know that these things takes several 100mil - bil dollars. looking at worldscale it could be possible.
side affect is that these peptides cant be sold for a premium anymore. Open licencing make competative pricing.
and more important, regulated Quality
BPC-157 has the better paper trail though. It's that stomach-derived fragment, and the animal work on tendons and gut healing is actually decent, not amazing, but decent enough that you could put together a real proposal a lab wouldn't laugh at. TB-500 is more thymosin-related, wound healing and cell migration, and honestly a lot of what people say about it online is just vibes carried over from BPC-157's reputation.
BPC-157 could be probably the honest move. and if such a campaign actually works and funds a real trial, TB-500 could be next because the same audience is already there and already primed for it.
I know that these things takes several 100mil - bil dollars. looking at worldscale it could be possible.
side affect is that these peptides cant be sold for a premium anymore. Open licencing make competative pricing.
and more important, regulated Quality